Tremfya

• Brands Tremfya
• Product Code: Tremfya

• Mechanism of Action

  Tremfya works by targeting IL-23, a cytokine involved in the differentiation and activation of T-helper cells, which play a central role in the inflammatory processes of autoimmune diseases. By inhibiting IL-23, Tremfya helps to reduce the inflammatory response associated with these conditions .

  Indications

  Tremfya is indicated for the treatment of

  • Plaque Psoriasis: Adults with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.

  • Psoriatic Arthritis: Adults with active psoriatic arthritis.

  • Crohn’s Disease: Adults with moderately to severely active Crohn’s disease.

  • Ulcerative Colitis: Adults with moderately to severely active ulcerative colitis 

  Administration & Dosing

  Tremfya is administered as a subcutaneous injection. The dosing schedule typically involves an initial dose, followed by maintenance doses every 8 weeks. Specific dosing schedules may vary based on the condition being treated and individual patient factors .

  Side Effects

  Common side effects of Tremfya may include:

  • Respiratory tract infections

  • Headache

  • Injection site reactions

  • Joint pain (arthralgia)

  • Diarrhea

  • Stomach flu (gastroenteritis)

  • Fungal skin infections

  • Herpes simplex infections

  • Stomach pain

  • Bronchitis 

  Patients should be monitored for signs of infection and other potential adverse effects during treatment.

• Availability: In Stock

• American Diabetes Association

• Diabetes Disaster_Response Coalition storing insulin

• FDA Approved Prescription